Search results
Dr. Reddy’s Laboratories, a leading multinational pharmaceutical company based in India and overseas, committed to providing affordable and innovative medicines for healthier lives.
Our products span across major therapeutic categories including gastrointestinal, cardiovascular, pain management, oncology, anti-infectives, pediatrics, and dermatology. A variety of forms, including tablets, capsules, injectables and topical creams, are available.
Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy , who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited . [2]
Product Websites. Sapropterin Dihydrochloride Patient Support Program. DOXOrubicin HCI Liposome. Bivalirudin. Sumatriptan Injection. Co-pay Card Programs. Fingolimod Capsules 0.5 mg Co-pay Card. Lenalidomide Capsules, 2.5 mg, 5 mg, 10 mg, 15 mg, and 25 mg Co-pay Card. Pyrimethamine Tablets USP, 25 mg Co-pay Card.
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) is a global pharmaceutical company headquartered in Hyderabad, India. Established in 1984, we are committed...
Dr. Reddy’s Laboratories commenced its generics business in India in 1986 and is today a trusted name in the healthcare industry consistently serving the needs of millions of patients with high quality, affordable and innovative medicines across therapy areas.
1 day ago · In recent trading, shares of Dr. Reddy's Laboratories Ltd. (Symbol: RDY) have crossed above the average analyst 12-month target price of $75.00, changing hands for $75.40/share.
